Impact Healthcare REIT (LON:IHR) Stock Price Down 0.6% - Time to Sell?

Impact Healthcare REIT (LON:IHR - Get Free Report) dropped 0.6% during trading on Friday . The company traded as low as GBX 87.90 ($1.15) and last traded at GBX 88.30 ($1.15). Approximately 1,227,837 shares traded hands during mid-day trading, an increase of 95% from the average daily volume of 630,263 shares. The stock had previously closed at GBX 88.80 ($1.16).

Analysts Set New Price Targets

Separately, Jefferies Financial Group reissued a "buy" rating and issued a GBX 114 ($1.49) price target on shares of Impact Healthcare REIT in a research note on Tuesday, July 2nd.

Impact Healthcare REIT Trading Down 0.6 %

The company has a market capitalization of £365.89 million, a PE ratio of 802.73, a PEG ratio of 1.95 and a beta of 0.37. The company has a fifty day simple moving average of GBX 89.58 and a 200-day simple moving average of GBX 87.31. The company has a current ratio of 1.58, a quick ratio of 2.37 and a debt-to-equity ratio of 37.83.

Impact Healthcare REIT Announces Dividend

The company also recently announced a dividend, which was paid on Friday, August 16th. Shareholders of record on Thursday, August 1st were issued a GBX 1.74 ($0.02) dividend. The ex-dividend date of this dividend was Thursday, August 1st. This represents a yield of 1.98%. Impact Healthcare REIT's payout ratio is 6,363.64%.

Impact Healthcare REIT Company Profile

Impact Healthcare REIT plc is a specialist and responsible owner of care homes and other healthcare properties across the UK. Elderly care is an essential service and demand for it is high and continues to grow as the UK's population gets older. We work with our tenants so we can grow together and help them care for more people, while continuing to improve our homes for their residents.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.